我武生物
(300357)
| 流通市值：142.56亿 | | | 总市值：154.20亿 |
| 流通股本：4.84亿 | | | 总股本：5.24亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 484,236,510.36 | 228,471,779.62 | 925,394,524.96 | 730,238,304.07 |
| 营业收入 | 484,236,510.36 | 228,471,779.62 | 925,394,524.96 | 730,238,304.07 |
| 二、营业总成本 | 288,042,152.3 | 144,752,871.67 | 578,606,136.89 | 427,571,052.51 |
| 营业成本 | 23,722,425.65 | 11,970,272.03 | 44,809,559.78 | 34,634,787.12 |
| 税金及附加 | 3,685,992.89 | 978,789.53 | 9,729,074.88 | 4,657,424.06 |
| 销售费用 | 178,121,714.43 | 92,234,264.06 | 361,427,171.25 | 270,793,761.25 |
| 管理费用 | 37,671,306.59 | 16,858,018.92 | 73,221,145.2 | 52,758,384.8 |
| 研发费用 | 58,829,519.3 | 29,641,964.59 | 119,882,840.88 | 87,862,042.99 |
| 财务费用 | -13,988,806.56 | -6,930,437.46 | -30,463,655.1 | -23,135,347.71 |
| 其中:利息费用 | 406,344.87 | 219,729.74 | 1,064,296.51 | 899,572.95 |
| 其中:利息收入 | 14,439,586.38 | 7,172,279.88 | 31,767,052.92 | 24,233,008.41 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 1,328,169.78 | 395,090.71 | 2,429,584.92 | -763,407.78 |
| 加:投资收益 | 16,143.8 | 151,575.33 | 4,040,186.3 | 6,482,593.58 |
| 资产处置收益 | 630,073.33 | 630,073.33 | 568,926.85 | 568,926.85 |
| 信用减值损失(新) | -2,207,917.71 | -979,914.68 | -958,291.22 | -4,921,945.92 |
| 其他收益 | 5,400,152.83 | 888,236.42 | 16,241,196.82 | 12,145,650.34 |
| 四、营业利润 | 201,360,980.09 | 84,803,969.06 | 369,109,991.74 | 316,179,068.63 |
| 加:营业外收入 | 91,358.37 | 4,952.11 | 196,084.76 | 354,565.55 |
| 减:营业外支出 | 1,923,245.66 | 849,500.88 | 4,244,303.61 | 3,009,469.52 |
| 五、利润总额 | 199,529,092.8 | 83,959,420.29 | 365,061,772.89 | 313,524,164.66 |
| 减:所得税费用 | 29,099,866.47 | 12,408,396.79 | 60,723,377.96 | 51,026,066.64 |
| 六、净利润 | 170,429,226.33 | 71,551,023.5 | 304,338,394.93 | 262,498,098.02 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 170,429,226.33 | 71,551,023.5 | 304,338,394.93 | 262,498,098.02 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 177,008,721.63 | 74,342,067.14 | 317,822,381.76 | 272,253,993.52 |
| 少数股东损益 | -6,579,495.3 | -2,791,043.64 | -13,483,986.83 | -9,755,895.5 |
| 扣除非经常损益后的净利润 | 172,590,977.7 | 73,618,428.11 | 306,309,299.41 | 263,748,769.9 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.34 | 0.14 | 0.61 | 0.52 |
| (二)稀释每股收益 | 0.34 | 0.14 | 0.61 | 0.52 |
| 八、其他综合收益 | -4,365.07 | -998.01 | 6,304.55 | -1,421.66 |
| 归属于母公司股东的其他综合收益 | -4,365.07 | -998.01 | 6,304.55 | -1,421.66 |
| 九、综合收益总额 | 170,424,861.26 | 71,550,025.49 | 304,344,699.48 | 262,496,676.36 |
| 归属于母公司股东的综合收益总额 | 177,004,356.56 | 74,341,069.13 | 317,828,686.31 | 272,252,571.86 |
| 归属于少数股东的综合收益总额 | -6,579,495.3 | -2,791,043.64 | -13,483,986.83 | -9,755,895.5 |
| 公告日期 | 2025-08-22 | 2025-04-19 | 2025-04-19 | 2024-10-24 |
| 审计意见(境内) | | | 标准无保留意见 | |